Loading...
XNASSTAA
Market cap1.13bUSD
Jan 10, Last price  
23.00USD
1D
-0.52%
1Q
-27.24%
Jan 2017
111.98%
Name

STAAR Surgical Co

Chart & Performance

D1W1MN
XNAS:STAA chart
P/E
53.09
P/S
3.52
EPS
0.43
Div Yield, %
0.00%
Shrs. gr., 5y
1.78%
Rev. gr., 5y
21.07%
Revenues
322m
+13.37%
51,685,00051,303,00056,282,00059,363,00074,894,00075,345,00054,958,00062,765,00063,783,00072,215,00074,987,00077,123,00082,432,00090,611,000123,954,000150,185,000163,460,000230,472,000284,391,000322,415,000
Net income
21m
-46.18%
-11,332,000-11,175,000-15,044,000-15,999,000-23,195,000-6,200,00053,0001,348,000-1,763,000398,000-8,392,000-6,533,000-12,129,000-2,139,0004,968,00014,048,0005,913,00027,511,00039,665,00021,347,000
CFO
15m
-59.14%
-8,804,000-6,976,000-8,647,000-11,184,000-8,228,0001,427,000-4,417,0005,346,0003,217,0003,352,000-7,951,000-2,162,0001,049,0002,853,00012,767,00025,795,00020,951,00043,962,00035,715,00014,594,000
Earnings
Feb 24, 2025

Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
IPO date
Feb 24, 1992
Employees
882
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122021‑002020‑002018‑122017‑122016‑122016‑00
Income
Revenues
322,415
13.37%
284,391
73.98%
Cost of revenue
292,926
240,589
Unusual Expense (Income)
NOPBT
29,489
43,802
NOPBT Margin
9.15%
15.40%
Operating Taxes
12,349
6,797
Tax Rate
41.88%
15.52%
NOPAT
17,140
37,005
Net income
21,347
-46.18%
39,665
570.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
(2,096)
1,000
BB yield
0.14%
0.00%
Debt
Debt current
8,734
3,693
Long-term debt
67,301
58,385
Deferred revenue
Other long-term liabilities
5,158
2,155
Net debt
(156,394)
(163,463)
Cash flow
Cash from operating activities
14,594
35,715
CAPEX
(18,188)
(18,108)
Cash from investing activities
74,347
(156,376)
Cash from financing activities
7,415
8,297
FCF
(49,510)
(46,429)
Balance
Cash
220,726
211,639
Long term investments
11,703
13,902
Excess cash
216,308
211,321
Stockholders' equity
(50,993)
(71,747)
Invested Capital
482,306
433,538
ROIC
3.74%
9.39%
ROCE
6.82%
12.06%
EV
Common stock shares outstanding
49,427
49,380
Price
31.21
-35.70%
48.54
-38.73%
Market cap
1,542,617
-35.64%
2,396,905
-36.90%
EV
1,386,223
2,233,442
EBITDA
34,613
48,311
EV/EBITDA
40.05
46.23
Interest
2,448
Interest/NOPBT
5.59%